ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Webcast Today - New Data from bioMUSE Natural History Study, page-70

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 797 Posts.
    lightbulb Created with Sketch. 229
    Hi Scott,In a recent post to Outlander2 on this ATH thread you suggested he look at PAA as worth a look at as it was in the neurodegenerative space with excellent prospects. Have you ever looked at PER for Duchene Muscular Dystrophy with its ATL1102 product? It is well placed with its trials. The only negative is the discussions on its HC threads are pretty wild (like IMU and BRN).Hope I dont get moderated!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.